Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

Recruiting Observational Study
Viral Hepatitis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,300 (estimated)
Sponsor
University Hospital, Limoges · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vuln…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult 18 and over * Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector * Patient not opposed to research Exclusion Criteria: * Age under 18 * Patient opposed to research
Contacts

Marilyne DEBETTE-GRATIEN, MD

+33555056604

marilyne.gratien@chu-limoges.fr

CONTACT